Clinical Trial Update: Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether L-Arginine improves cognitive function in elderly individuals with cognitive disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Disorders in the Elderly
• Cognitive Impairment

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: German University in Cairo | Conditions: Cognition Disorders in Old Age, Cognitive and Behavioral Impairment | Phase 2 | Status: RECRUITING